Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Deliang Zhou is active.

Publication


Featured researches published by Deliang Zhou.


Journal of Pharmaceutical Sciences | 2011

Dissolution and precipitation behavior of amorphous solid dispersions.

David E. Alonzo; Yi Gao; Deliang Zhou; Huaping Mo; Geoff G. Z. Zhang; Lynne S. Taylor

Amorphous solid dispersions (ASDs) are widely utilized in the pharmaceutical industry for bioavailability enhancement of low solubility drugs. The important factors governing the dissolution behavior of these systems are still far from adequately understood. As a consequence, it is of interest to investigate the behavior of these systems during the dissolution process. The purpose of this research was twofold. First, the degree of supersaturation generated upon dissolution as a function of drug-polymer composition was investigated. Second, an investigation was conducted to correlate physical behavior upon dissolution with polymer loading. Felodipine and indomethacin were selected as model drugs and hydroxypropylmethylcellulose (HPMC) and polyvinylpyrrolidone (PVP) were used to form the dispersions. Diffusion and nuclear magnetic resonance spectroscopy experiments revealed that the extent of bulk supersaturation generated on dissolution of the ASD did not depend on the drug-polymer ratio. Interestingly, the maximum supersaturation generated was similar to the predicted amorphous solubility advantage. However, dynamic light scattering measurements revealed that particles on the submicron scale were generated during dissolution of the solid dispersions containing 90% polymer, whereas solid dispersions at a 50% polymer loading did not yield these nanoparticles. The nanoparticles were found to result in anomalous concentration measurements when using in situ ultraviolet spectroscopy. The supersaturation generated upon dissolution of the solid dispersions was maintained for biologically relevant timeframes for the HPMC dispersions, whereas PVP appeared to be a less effective crystallization inhibitor.


Molecular Pharmaceutics | 2008

Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.

Deliang Zhou; Geoff G. Z. Zhang; Devalina Law; David J. W. Grant; Eric A. Schmitt

Griseofulvin is a small rigid molecule that shows relatively high molecular mobility and small configurational entropy in the amorphous phase and tends to readily crystallize from both rubbery and glassy states. This work examines the crystallization kinetics and mechanism of amorphous griseofulvin and the quantitative correlation between the rate of crystallization and molecular mobility above and below Tg. Amorphous griseofulvin was prepared by rapidly quenching the melt in liquid N2. The thermodynamics and dynamics of amorphous phase were then characterized using a combination of thermal analysis techniques. After characterization of the amorphous phase, crystallization kinetics above Tg were monitored by isothermal differential scanning calorimetry (DSC). Transformation curves for crystallization fit a second-order John-Mehl-Avrami (JMA) model. Crystallization kinetics below Tg were monitored by powder X-ray diffraction and fit to the second-order JMA model. Activation energies for crystallization were markedly different above and below Tg suggesting a change in mechanism. In both cases molecular mobility appeared to be partially involved in the rate-limiting step for crystallization, but the extent of correlation between the rate of crystallization and molecular mobility was different above and below Tg. A lower extent of correlation below Tg was observed which does not appear to be explained by the molecular mobility alone and the diminishing activation energy for crystallization suggests a change in the mechanism of crystallization.


Developing Solid Oral Dosage Forms (Second Edition)#R##N#Pharmaceutical Theory and Practice | 2009

Drug Stability and Degradation Studies

Deliang Zhou; William R. Porter; Geoff G.Z. Zhang

Publisher Summary This chapter discusses the basic treatments of drug degradation studies, including kinetics, pathways, important factors, and typical practices for assessing both chemical and physical stability of pharmaceutical compounds. Chemical degradation reactions of pharmaceuticals follow the well-established treatments of chemical kinetics. When a chemical reaction starts, the concentrations of reactants and products change with time until the reaction reaches completion or equilibrium. The concentrations of the reactants decrease, while those of the products increase over time. Therefore, the rate of a reaction can be represented either by the decreasing change in the concentration of a reactant or the increasing change in the concentration of a product with respect to time. Many reactions involve more than a single step, and are known as complex reactions. Depending on the reaction schemes, and the magnitude of respective rate constants, the overall kinetics may be approximated by zero-, first- or second-order rate equations. Water is ubiquitously present as atmospheric moisture, and has a profound effect on solid-state reactions. Water can act as a reactant, and be involved in the reaction itself, such as in hydrolytic reactions, and also it is an excellent plasticizer; it increases molecular mobility of reactants and enhances drug degradation.


Journal of Pharmaceutical Sciences | 2014

Understanding and Managing the Impact of HPMC Variability on Drug Release from Controlled Release Formulations

Deliang Zhou; Devalina Law; Judie Reynolds; Lynn Davis; Clifford Smith; Jose L. Torres; Viraj Dave; Nishanth Gopinathan; Daniel T. Hernandez; Mary Kay Springman; Casey Chun Zhou

The purpose of this study is to identify critical physicochemical properties of hydroxypxropyl methylcellulose (HPMC) that impact the dissolution of a controlled release tablet and develop a strategy to mitigate the HPMC lot-to-lot and vendor-to-vendor variability. A screening experiment was performed to evaluate the impacts of methoxy/hydroxypropyl substitutions, and viscosity on drug release. The chemical diversity of HPMC was explored by nuclear magnetic resonance (NMR), and the erosion rate of HPMC was investigated using various dissolution apparatuses. Statistical evaluation suggested that the hydroxypropyl content was the primary factor impacting the drug release. However, the statistical model prediction was not robust. NMR experiments suggested the existence of structural diversity of HPMC between lots and more significantly between vendors. Review of drug release from hydrophilic matrices indicated that erosion is a key aspect for both poorly soluble and soluble drugs. An erosion rate method was then developed, which enabled the establishment of a robust model and a meaningful HPMC specification. The study revealed that the overall substitution level is not the unique parameter that dictates its release-controlling properties. Fundamental principles of polymer chemistry and dissolution mechanisms are important in the development and manufacturing of hydrophilic matrices with consistent dissolution performance.


Developing Solid Oral Dosage Forms (Second Edition)#R##N#Pharmaceutical Theory and Practice | 2017

Crystalline and Amorphous Solids

Geoff G. Z. Zhang; Deliang Zhou

Abstract Of the several states of matter in which a substance can reside, the solid state is most commonly encountered; therefore, it is the most important and relevant state for pharmaceutical development. Most of the pharmaceutical products on the market or formulations presently being developed are in the solid dosage form. Even when a product is marketed or developed as a solution or a semisolid formulation, a solid is usually selected and manufactured as an active pharmaceutical ingredient for such reasons as the ability to crystallize (and therefore to be purified), ease of handling, and better chemical stability in comparison with liquids. Therefore, an understanding of the various solid forms that may occur, as well as the rational selection of solid forms for development, are critical to the facile development of a particular chemical entity. Many books and special journal issues are devoted to this topic. This chapter, due to space limitations, provides only a brief introduction to the fundamental principles and practical aspects of pharmaceutical solids. Interested readers are encouraged to read the books and reviews cited here.


Journal of Pharmaceutical Sciences | 2011

A Novel Accelerated Oxidative Stability Screening Method for Pharmaceutical Solids

Donghua Alan Zhu; Geoff G. Z. Zhang; Karen L.S.T. George; Deliang Zhou

Despite the fact that oxidation is the second most frequent degradation pathway for pharmaceuticals, means of evaluating the oxidative stability of pharmaceutical solids, especially effective stress testing, are still lacking. This paper describes a novel experimental method for peroxide-mediated oxidative stress testing on pharmaceutical solids. The method utilizes urea-hydrogen peroxide, a molecular complex that undergoes solid-state decomposition and releases hydrogen peroxide vapor at elevated temperatures (e.g., 30°C), as a source of peroxide. The experimental setting for this method is simple, convenient, and can be operated routinely in most laboratories. The fundamental parameter of the system, that is, hydrogen peroxide vapor pressure, was determined using a modified spectrophotometric method. The feasibility and utility of the proposed method in solid form selection have been demonstrated using various solid forms of ephedrine. No degradation was detected for ephedrine hydrochloride after exposure to the hydrogen peroxide vapor for 2 weeks, whereas both anhydrate and hemihydrate free base forms degraded rapidly under the test conditions. In addition, both the anhydrate and the hemihydrate free base degraded faster when exposed to hydrogen peroxide vapor at 30°C under dry condition than at 30°C/75% relative humidity (RH). A new degradation product was also observed under the drier condition. The proposed method provides more relevant screening conditions for solid dosage forms, and is useful in selecting optimal solid form(s), determining potential degradation products, and formulation screening during development.


Pharmaceutical Research | 2010

Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution

David E. Alonzo; Geoff G. Z. Zhang; Deliang Zhou; Yi Gao; Lynne S. Taylor


Journal of Pharmaceutical Sciences | 2002

Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility

Deliang Zhou; Geoff G. Z. Zhang; Devalina Law; David J.W. Grant; Eric A. Schmitt


Crystal Growth & Design | 2012

Characterizing the Impact of Hydroxypropylmethyl Cellulose on the Growth and Nucleation Kinetics of Felodipine from Supersaturated Solutions

David E. Alonzo; Shweta A. Raina; Deliang Zhou; Yi Gao; Geoff G. Z. Zhang; Lynne S. Taylor


Journal of Pharmaceutical Sciences | 2003

Crystallization kinetics of amorphous nifedipine studied by model‐fitting and model‐free approaches

Deliang Zhou; Eric A. Schmitt; Geoff G. Z. Zhang; Devalina Law; Sergey Vyazovkin; Charles A. Wight; David J.W. Grant

Collaboration


Dive into the Deliang Zhou's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Devalina Law

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar

Michael G. Fickes

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sergey Vyazovkin

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Rodger F. Henry

Northern Illinois University

View shared research outputs
Researchain Logo
Decentralizing Knowledge